Great Lakes Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.1M | Sell |
3,991
-114
| -3% | -$63.9K | 0.02% | 419 |
|
|
2026
Q1 | $2.31M | Sell |
4,105
-172
| -4% | -$110K | 0.02% | 386 |
|
|
2025
Q4 | $2.89M | Buy |
4,277
+62
| +1% | +$42.2K | 0.02% | 352 |
|
|
2025
Q3 | $2.69M | Sell |
4,215
-228
| -5% | -$138K | 0.02% | 380 |
|
|
2025
Q2 | $2.38M | Buy |
4,443
+1,876
| +73% | +$897K | 0.02% | 416 |
|
|
2025
Q1 | $1.08M | Buy |
2,567
+23
| +0.9% | +$9.99K | 0.01% | 499 |
|
|
2024
Q4 | $1.05M | Sell |
2,544
-17
| -0.7% | -$7.46K | 0.01% | 572 |
|
|
2024
Q3 | $1.29M | Sell |
2,561
-15
| -0.6% | -$7.29K | 0.01% | 546 |
|
|
2024
Q2 | $1.26M | Sell |
2,576
-112
| -4% | -$56.2K | 0.01% | 543 |
|
|
2024
Q1 | $1.45M | Sell |
2,688
-495
| -16% | -$271K | 0.01% | 506 |
|
|
2023
Q4 | $1.77M | Sell |
3,183
-1,371
| -30% | -$644K | 0.02% | 469 |
|
|
2023
Q3 | $1.99M | Sell |
4,554
-1,321
| -22% | -$659K | 0.02% | 455 |
|
|
2023
Q2 | $2.95M | Buy |
5,875
+3,087
| +111% | +$1.48M | 0.03% | 412 |
|
|
2023
Q1 | $1.39M | Sell |
2,788
-78
| -3% | -$37.3K | 0.01% | 534 |
|
|
2022
Q4 | $1.17M | Sell |
2,866
-79
| -3% | -$30.7K | 0.07% | 388 |
|
|
2022
Q3 | $959K | Sell |
2,945
-175
| -6% | -$64.3K | 0.02% | 414 |
|
|
2022
Q2 | $1.09M | Sell |
3,120
-75
| -2% | -$30.6K | 0.02% | 423 |
|
|
2022
Q1 | $1.75M | Sell |
3,195
-3,378
| -51% | -$1.78M | 0.03% | 397 |
|
|
2021
Q4 | $4.33M | Sell |
6,573
-14
| -0.2% | -$8.79K | 0.07% | 286 |
|
|
2021
Q3 | $4.1M | Sell |
6,587
-16
| -0.2% | -$10.8K | 0.06% | 284 |
|
|
2021
Q2 | $4.17M | Sell |
6,603
-895
| -12% | -$494K | 0.06% | 301 |
|
|
2021
Q1 | $3.67M | Sell |
7,498
-4,623
| -38% | -$2.32M | 0.06% | 304 |
|
|
2020
Q4 | $6.06M | Sell |
12,121
-251
| -2% | -$112K | 0.11% | 215 |
|
|
2020
Q3 | $4.86M | Buy |
12,372
+2,626
| +27% | +$971K | 0.1% | 226 |
|
|
2020
Q2 | $3.22M | Buy |
9,746
+5
| +0.1% | +$1.45K | 0.08% | 268 |
|
|
2020
Q1 | $2.36M | Buy |
9,741
+201
| +2% | +$52.5K | 0.07% | 278 |
|
|
2019
Q4 | $2.49M | Sell |
9,540
-420
| -4% | -$111K | 0.05% | 315 |
|
|
2019
Q3 | $2.71M | Hold |
9,960
| – | – | 0.06% | 304 |
|
|
2019
Q2 | $2.74M | Sell |
9,960
-1,007
| -9% | -$248K | 0.06% | 304 |
|
|
2019
Q1 | $2.45M | Sell |
10,967
-169
| -2% | -$34.9K | 0.05% | 310 |
|
|
2018
Q4 | $2.07M | Sell |
11,136
-2,630
| -19% | -$539K | 0.05% | 312 |
|
|
2018
Q3 | $3.44M | Buy |
13,766
+142
| +1% | +$34.5K | 0.08% | 250 |
|
|
2018
Q2 | $2.97M | Buy |
13,624
+10,118
| +289% | +$2.08M | 0.07% | 267 |
|
|
2018
Q1 | $671K | Sell |
3,506
-6
| -0.2% | -$1.11K | 0.02% | 402 |
|
|
2017
Q4 | $549K | Sell |
3,512
-1,127
| -24% | -$177K | 0.01% | 446 |
|
|
2017
Q3 | $721K | Sell |
4,639
-48,139
| -91% | -$7.61M | 0.02% | 404 |
|
|
2017
Q2 | $8.52M | Buy |
52,778
+8,509
| +19% | +$1.38M | 0.21% | 84 |
|
|
2017
Q1 | $6.84M | Buy |
44,269
+5,856
| +15% | +$807K | 0.18% | 94 |
|
|
2016
Q4 | $4.5M | Buy |
38,413
+284
| +0.7% | +$32.4K | 0.12% | 144 |
|
|
2016
Q3 | $4.3M | Sell |
38,129
-4,227
| -10% | -$446K | 0.12% | 142 |
|
|
2016
Q2 | $3.93M | Buy |
42,356
+31,005
| +273% | +$2.66M | 0.11% | 174 |
|
|
2016
Q1 | $889K | Buy |
+11,351
| New | +$817K | 0.02% | 361 |
|
Other funds holding IDXX
Great Lakes Advisors's IDXX Position: Q2 2026 in Review
Great Lakes Advisors reduced its Idexx Laboratories (IDXX) stake by 2.8% in Q2 2026, selling an estimated $63.9K and leaving 3,991 shares worth $2.1M. The position accounts for 0.02% of the portfolio, ranked #419.
Great Lakes Advisors first reported a position in IDXX in Q1 2016 and has held it in 42 quarters since. The position peaked at $8.52M in Q2 2017. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Great Lakes Advisors held 3,991 shares of Idexx Laboratories worth $2.1M as of Q2 2026.
- Great Lakes Advisors sold 114 Idexx Laboratories shares in Q2 2026, an estimated $63.9K.
- Idexx Laboratories made up 0.02% of Great Lakes Advisors's portfolio in Q2 2026, its #419 holding.
- Great Lakes Advisors first reported a position in Idexx Laboratories in Q1 2016 and has held it in 42 quarters since.
- Great Lakes Advisors's Idexx Laboratories position peaked at $8.52M in Q2 2017.
- 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.